Fox Chase Cancer Center News

PHILADELPHIA (March 16, 2017) — Fox Chase Cancer Center researchers Igor Astsaturov, MD, PhD, and Linara Gabitova, PhD, have shown for the first time that pancreatic cancer cells are dependent on cholesterol metabolism to form and grow. The study also singled out an enzyme that could be targeted to eliminate cholesterol production within the pancreas. A poster of the study is being presented at the American Association for Cancer Research (AACR) Annual Meeting 2017 in Washington, DC on Sunday, April 2.

PHILADELPHIA (March 9, 2017) – Specialists from Fox Chase Cancer Center and the Temple Head & Neck Institute (THNI) will offer free oral cancer screenings in observance of the 20th annual Oral, Head, and Neck Cancer Awareness Week® (OHANCAW®) taking place April 2-9, 2017.

PHILADELPHIA (March 7, 2017) — Fox Chase Cancer Center is pleased to announce its continuing support for the Colon Cancer Coalition’s Annual Get Your Rear in Gear run/walk. Faculty, staff, volunteers, patients, survivors, and their families will come together as members of the Fox Chase team on Sunday, March 26.

PHILADELPHIA (March 1, 2017) – In honor of National Colorectal Cancer Awareness Month, Fox Chase Cancer Center is urging both patients to schedule a colorectal cancer screening.  One’s lifetime risk of developing colorectal cancer is approximately 1 in 21 (4.7%) for men and 1 in 23 (4.4%) for women.

PHILADELPHIA (February 21, 2017)— Eric M. Horwitz, MD, chair of the Department of Radiation Oncology at Fox Chase Cancer Center, has been selected by the American Brachytherapy Society (ABS) as an inaugural ABS Fellow. He will be formally recognized at the ABS 2017 Annual Conference in Boston in April. 

PHILADELPHIA (February 15, 2017) – Dr. Finestone, will start at the Center’s department of medicine on February 15, 2017.

PHILADELPHIA (February 8, 2017) – The Fox Chase-Temple University Hospital Bone Marrow Transplant Program has received internationally-recognized accreditation by the Foundation for the Accreditation of Cellular Therapy (FACT) at the University of Nebraska Medical Center for adult allogeneic and autologous hematopoietic progenitor cell transplantation, peripheral blood cellular therapy product collection, and cellular therapy product processing with minimal manipulation. 

PHILADELPHIA (February 2, 2017) – In the largest study of its kind to date, researchers from Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University confirmed that oral antibiotics combined with mechanical bowel preparation were more effective at preventing surgical site infections after elective colorectal surgery compared to no bowel preparation or use of mechanical bowel preparation alone. Nestor F. Esnaola, MD, MPH, professor of surgical oncology at Fox Chase, led the study, which appears in Annals of Surgery.